Logo image of PTGX

PROTAGONIST THERAPEUTICS INC (PTGX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:PTGX - US74366E1029 - Common Stock

82.34 USD
+0.07 (+0.09%)
Last: 1/7/2026, 8:00:01 PM
82.34 USD
0 (0%)
After Hours: 1/7/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
PTGX revenue by date.PTGX revenue by date.
26.58M
-2.85%
60M
125.73%
434.433M
624.06%
67.749M
-84.41%
263.53M
288.98%
194.7M
-26.12%
278.62M
43.10%
477.13M
71.25%
670.71M
40.57%
873.88M
30.29%
1.091B
24.85%
EBITDA
YoY % growth
PTGX ebitda by date.PTGX ebitda by date.
-130.34M
-4.24%
-90.34M
30.69%
255.738M
383.08%
-148.008M
-157.87%
71.415M
148.25%
-58.288M
-181.62%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
PTGX ebit by date.PTGX ebit by date.
-131.37M
-4.39%
-93.652M
28.71%
252.843M
369.98%
-151.762M
-160.02%
24.465M
116.12%
-98.591M
-502.99%
35.515M
136.02%
221.36M
523.29%
396.57M
79.15%
645.82M
62.85%
851.53M
31.85%
Operating Margin
PTGX operating margin by date.PTGX operating margin by date.
-494.24%-156.09%58.20%-224.01%9.28%-50.64%12.75%46.39%59.13%73.90%78.05%
EPS
YoY % growth
PTGX eps by date.PTGX eps by date.
-2.60
3.70%
-1.49
42.69%
4.20
381.88%
-1.95
-146.53%
-0.14
92.89%
-1.28
-818.92%
1.25
197.73%
3.92
214.17%
5.15
31.40%
5.79
12.48%
7.79
34.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.62
-131.09%
-0.51
-168.66%
-0.05
91.24%
0.24
138.81%
-0.39
37.22%
Revenue
Q2Q % growth
9.105M
-94.66%
22.079M
-22.04%
14.849M
167.74%
105.46M
2,138.12%
122.11M
1,241.13%
EBITDA
Q2Q % growth
-50.916M
-139.26%
-909.84K
95.23%
-2.19M
94.72%
-2.515M
94.47%
N/A
EBIT
Q2Q % growth
-44.537M
-135.13%
-43.214M
-123.79%
92.514M
320.06%
44.778M
196.46%
53.108M
219.25%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.62
-14.81%
-0.650.034.88%
Q2 2025
Q2Q % growth
-0.55
-10.00%
-0.590.046.78%
Q1 2025
Q2Q % growth
-0.19
-105.83%
-0.240.0519.40%
Q4 2024
Q2Q % growth
1.98
350.00%
0.331.65504.52%
Q3 2024
Q2Q % growth
-0.54
6.90%
-0.620.0812.85%
Q2 2024
Q2Q % growth
-0.50
26.47%
-0.610.1118.53%
Q1 2024
Q2Q % growth
3.26
586.57%
1.222.04167.72%
Q4 2023
Q2Q % growth
0.44
163.77%
-0.030.471,399.31%
Q3 2023
Q2Q % growth
-0.58
9.38%
-0.710.1318.05%
Q2 2023
Q2Q % growth
-0.68
19.05%
-0.66-0.02-2.99%
Q1 2023
Q2Q % growth
-0.67
-55.81%
-0.740.079.61%
Q4 2022
Q2Q % growth
-0.69
10.39%
-0.65-0.04-5.98%
Q3 2022
Q2Q % growth
-0.64
8.57%
-0.890.2527.71%
Q2 2022
Q2Q % growth
-0.84
-21.74%
-0.950.1111.13%
Q1 2022
Q2Q % growth
-0.43
20.37%
-0.640.2132.91%
Q4 2021
Q2Q % growth
-0.77
-60.42%
-0.800.033.53%
Q3 2021
Q2Q % growth
-0.70
-233.33%
-0.68-0.02-2.43%
Q2 2021
Q2Q % growth
-0.69
-13.11%
-0.56-0.13-23.64%
Q1 2021
Q2Q % growth
-0.54
25.00%
-0.580.046.79%
Q4 2020
Q2Q % growth
-0.48 -0.490.011.55%
Q3 2020
Q2Q % growth
-0.21 -0.620.4166.39%
Q2 2020
Q2Q % growth
-0.61 -0.610.00-0.51%
Q1 2020
Q2Q % growth
-0.72 -0.71-0.01-2.01%
PTGX Yearly EPS VS EstimatesPTGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
4.712M
0.79%
3.709M1.003M27.04%
Q2 2025
Q2Q % growth
5.546M
33.09%
6.942M-1.396M-20.11%
Q1 2025
Q2Q % growth
28.321M
-88.89%
31.053M-2.732M-8.80%
Q4 2024
Q2Q % growth
170.638M
184.40%
51.36M119.278M232.24%
Q3 2024
Q2Q % growth
4.675M 2.113M2.562M121.25%
Q2 2024
Q2Q % growth
4.167M 8.16M-3.993M-48.93%
Q1 2024
Q2Q % growth
254.953M 122.4M132.553M108.29%
Q4 2023
Q2Q % growth
60M 40.8M19.2M47.06%
Q3 2023
Q2Q % growth
8.5M-8.5M-100.00%
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
2.04M-2.04M-100.00%
Q4 2022
Q2Q % growth

-100.00%
5.1M-5.1M-100.00%
Q3 2022
Q2Q % growth

-100.00%
%
Q2 2022
Q2Q % growth
860K
-62.11%
390.997K469.003K119.95%
Q1 2022
Q2Q % growth
25.72M
315.51%
17.391M8.329M47.89%
Q4 2021
Q2Q % growth
8.62M
52.57%
5.173M3.447M66.63%
Q3 2021
Q2Q % growth
10.29M
-21.51%
1.778M8.512M478.74%
Q2 2021
Q2Q % growth
2.27M
-63.50%
5.275M-3.005M-56.97%
Q1 2021
Q2Q % growth
6.19M
69.59%
1.53M4.66M304.58%
Q4 2020
Q2Q % growth
5.65M 3.188M2.462M77.23%
Q3 2020
Q2Q % growth
13.11M 2.193M10.917M497.81%
Q2 2020
Q2Q % growth
6.22M 2.584M3.636M140.71%
Q1 2020
Q2Q % growth
3.65M 1.51M2.14M141.72%
PTGX Yearly Revenue VS EstimatesPTGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.22% -1.4% 0.94% 4.32%
Revenue-65.91% 40.29% 2.46% 45.14%